Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study

Given the COVID-19 pandemic, currently, there are many drugs in clinical trials against this virus. Among the excellent drug targets of SARS-CoV-2 are its proteases (Nsp3 and Nsp5) that plays vital role in polyprotein processing giving rise to functional nonstructural proteins, essential for viral r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biomol Struct Dyn
Main Authors: Kumar, Prateek, Bhardwaj, Taniya, Kumar, Ankur, Gehi, Bhuvaneshwari R., Kapuganti, Shivani K., Garg, Neha, Nath, Gopal, Giri, Rajanish
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678354/
https://ncbi.nlm.nih.gov/pubmed/33179586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1845976
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados